Professor Sir Marc Feldmann
individual
About
Professor Sir Marc Feldmann is a British-Australian immunologist and Emeritus Professor at the University of Oxford's Kennedy Institute of Rheumatology. He is best known for co-discovering the role of TNF in inflammatory disease and helping establish anti-TNF therapy, a major biologics class in autoimmune medicine. Public filings also place him in company-building roles including co-founder and board member of Enosi Life Sciences, chairman of Hemogenyx Pharmaceuticals, and he is listed in your database as Chairman & Co-founder of Etheros Pharmaceuticals.
Areas of interest
longevitybiotechimmunologyautoimmune diseaserheumatologytherapeutic antibodiesinflammationneuroprotectionhealthspaninfectious disease